DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Gujarat Kidney And Super Speciality Limited — Updates

NSE 6d ago·24 Aug 2026, 1:24 pm

Gujarat Kidney And Super Speciality

Gujarat Kidney And Super Speciality Limited has announced that its board has appointed an additional director. This appointment is currently pending shareholder approval at the upcoming Annual General Meeting (AGM).

This corporate action is a routine procedural update rather than a major strategic shift. It indicates the company is continuing its governance practices and preparing for its next shareholder meeting. For investors, this news is neutral and primarily serves to keep the company's compliance status current with stock exchange regulations.

Investors should monitor the AGM date and the specific background of the proposed appointee. The focus should remain on the company's core operations and financial performance rather than this administrative update.